Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven E Reis

Showing results (151-160 of 181) with videos related to

Pageof 19
Sort By:
Circulation|August 23, 2006
The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health--National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome EvaluationLeslee J Shaw, C Noel Bairey Merz, Carl J Pepine, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
Risk factors for heart failure in women with ischemia and no obstructive coronary artery diseaseDerek Leong, Benita Tjoe, Parham Zarrini, et al.
Journal of the American Heart Association|September 2, 2017
Sudden Cardiac Death in Women With Suspected Ischemic Heart Disease, Preserved Ejection Fraction, and No Obstructive Coronary Artery Disease: A Report From the Women's Ischemia Syndrome Evaluation StudyPuja K Mehta, B Delia Johnson, Tanya S Kenkre, et al.
Clinical Cardiology|May 20, 2009
Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome EvaluationChristopher B Arant, Timothy R Wessel, Paul M Ridker, et al.
JAMIA Open|November 27, 2018
Accrual to Clinical Trials (ACT): A Clinical and Translational Science Award Consortium NetworkShyam Visweswaran, Michael J Becich, Vincent S D'Itri, et al.
Medrxiv : the Preprint Server for Health Sciences|November 19, 2025
Cross-cohort validation and cutpoint estimation of the Janssen plasma p-tau217+ assay in predominantly cognitively normal community cohortsWasiu G Balogun, Xuemei Zeng, Gallen Triana-Baltzer, et al.
Neurobiology of Aging|April 6, 2024
Apolipoprotein E and Alzheimer's disease pathology in African American older adultsSarah K Royse, Beth E Snitz, Ashley V Hill, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 22, 2025
Cross-cohort validation and cutpoint estimation of the Janssen plasma p-tau217+ assay in predominantly cognitively normal community studiesWasiu G Balogun, Xuemei Zeng, Gallen Triana-Baltzer, et al.
Journal of the American College of Cardiology|February 7, 2006
Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary diseaseC Noel Bairey Merz, Leslee J Shaw, Steven E Reis, et al.
Journal of the American College of Cardiology|February 11, 2003
Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE studyC Noel Bairey Merz, B Delia Johnson, Barry L Sharaf, et al.
Pageof 19

Showing results (151-160 of 181) with videos related to

Sort By:
Pageof 19
Circulation|August 23, 2006
The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health--National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome EvaluationLeslee J Shaw, C Noel Bairey Merz, Carl J Pepine, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
Risk factors for heart failure in women with ischemia and no obstructive coronary artery diseaseDerek Leong, Benita Tjoe, Parham Zarrini, et al.
Journal of the American Heart Association|September 2, 2017
Sudden Cardiac Death in Women With Suspected Ischemic Heart Disease, Preserved Ejection Fraction, and No Obstructive Coronary Artery Disease: A Report From the Women's Ischemia Syndrome Evaluation StudyPuja K Mehta, B Delia Johnson, Tanya S Kenkre, et al.
Clinical Cardiology|May 20, 2009
Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome EvaluationChristopher B Arant, Timothy R Wessel, Paul M Ridker, et al.
JAMIA Open|November 27, 2018
Accrual to Clinical Trials (ACT): A Clinical and Translational Science Award Consortium NetworkShyam Visweswaran, Michael J Becich, Vincent S D'Itri, et al.
Medrxiv : the Preprint Server for Health Sciences|November 19, 2025
Cross-cohort validation and cutpoint estimation of the Janssen plasma p-tau217+ assay in predominantly cognitively normal community cohortsWasiu G Balogun, Xuemei Zeng, Gallen Triana-Baltzer, et al.
Neurobiology of Aging|April 6, 2024
Apolipoprotein E and Alzheimer's disease pathology in African American older adultsSarah K Royse, Beth E Snitz, Ashley V Hill, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 22, 2025
Cross-cohort validation and cutpoint estimation of the Janssen plasma p-tau217+ assay in predominantly cognitively normal community studiesWasiu G Balogun, Xuemei Zeng, Gallen Triana-Baltzer, et al.
Journal of the American College of Cardiology|February 7, 2006
Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary diseaseC Noel Bairey Merz, Leslee J Shaw, Steven E Reis, et al.
Journal of the American College of Cardiology|February 11, 2003
Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE studyC Noel Bairey Merz, B Delia Johnson, Barry L Sharaf, et al.
Pageof 19